“India should focus on innovating drugs and molecules to emerge as a global leader”
Bio Spectrum|May 2021
The Organisation of Pharmaceutical Producers of India (OPPI) has elected S Sridhar as its next President for a period of two years, effective from February 15, 2021. He takes over from Sharad Tyagi, Former Managing Director, Boehringer Ingelheim India Pvt Ltd. Sridhar is currently serving as the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India. Sridhar has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group. He is a strong voice of healthcare transformation in the country and was the chair of FICCI’s Pharma Committee till recently. In conversation with BioSpectrum, S Sridhar talks about making a difference to patients, the industry and the country via this new role.
Prabhat Prakash

S Sridhar, President, Organisation of Pharmaceutical Producers of India (OPPI), Mumbai

What is your vision for the pharma sector during your tenure as OPPI President?

I am enthusiastic to be a part of the transformation that OPPI envisions for the Indian healthcare sector. For us, fostering an environment for research and innovation in the country, increasing access and leveraging technology would be the main patient- centric themes. I believe the research-based pharmaceutical industry has a great role to play in India’s journey to transform its healthcare and bring in new and better solutions to in the country.

Will the Budget 2021 help the pharma sector in becoming self-reliant and sustainable?

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM BIO SPECTRUMView All

“Our allergic rhinitis drug is technologically superior, masks bitterness and 52% cheaper”

Alok Malik, Group Vice President & Head, India Formulations, Glenmark Pharmaceuticals, Mumbai

5 mins read
Bio Spectrum
August 2021

Techade REDEFINING FUTURE OF life sciences industry

Digital transformation is the topmost priority for global corporations and in a highly connected world that will remain largely contactless for an extended period, there are shifts in business models, customer experience, operations, and employee experience. With technology adoption accelerating across sectors, 2021 is likely to put the spotlight on the emergence of growth verticals in the life sciences sector namely healthcare, pharma, medical devices, diagnostics etc. India is now standing at the cusp of a re-imagined decade of technology, commonly being referred to as ‘Techade’. While we anticipate a significantly better global economic growth this year as compared to 2020, we are also very much looking forward to the enhancement being brought to the Indian life sciences industry as it continues its transformation journey in this redefined techade.

10+ mins read
Bio Spectrum
August 2021

Multifarious Cataract cures emerge

Being documented as India’s most significant cause of bilateral blindness that is for both eyes, cataract has become an economic and social burden that is increasing with the ageing population.

3 mins read
Bio Spectrum
August 2021

WHO Updates Guidelines For TB Detection

The World Health Organization (WHO) has issued an update to its consolidated guidelines on the detection of tuberculosis (TB) and drug-resistant TB.

1 min read
Bio Spectrum
August 2021

Is The 5G Health Scare Unfounded?

The introduction of the 5G network has been mired in numerous controversies. Governments across the globe, activists and telecom operators are embroiled in a bitter fight, filing lawsuits and protesting in large numbers. Although most of the available research on electromagnetic fields (EMF) reveals that there are no harmful effects from mobile radiation, some studies do reveal that it has the potential to damage the very structure of the DNA. Cancer, impaired reproductive health and numerous other disorders, including psychiatric, have been attributed to 5G. Will the implementation of the 5G network have serious health implications, or are these fears unfounded? We try to weigh-in the opposing sides.

8 mins read
Bio Spectrum
August 2021

Is Antibody Cocktail Offering The Right Mix?

Although the clinical outcomes, as well as clinical trials, have been very promising for patients treated with the antibody cocktail so far, the Delta plus variant is considered to be resistant to the monoclonal antibody (mAb) cocktail treatment.

6 mins read
Bio Spectrum
August 2021

Stride Ventures leads Rs 25 Cr debt round in MediBuddy

Stride Ventures, one of India’s leading venture debt funds, has led a debt round of Rs 25 crore in Bengaluru-based startup MediBuddy that helps its users consult specialist doctors, order medicines and book lab tests from the comfort of their homes.

1 min read
Bio Spectrum
July 2021

‘‘We see growing interest of healthcare testing labs, Pharmaceutical QC and R&D labs in implementing next-gen lab automation solutions''

US-based Abbott Informatics, formerly known as STARLIMS, is one of the companies with a long and established presence in the space of lab automation. Taking pride in offering the world class technological solutions, the company has recently announced the launch of STARLIMS Quality Manufacturing Solution QM12.2 which is built on the latest STARLIMS Technology V12 platform, along with STARLIMS SDMS (Scientific Data Management System) V12.2. To find out more about the company’s automated offerings in India, BioSpectrum spoke to Pradeep Nagisetty, Regional Sales Manager - India & Sub Continent, Abbott Informatics - STARLIMS, Hyderabad.

5 mins read
Bio Spectrum
July 2021

‘Juvenile Idiopathic Arthritis' remains a puzzle

LET'S TALK HEALTH & SCIENCE

3 mins read
Bio Spectrum
July 2021

India proposes BRICS Consortium to tackle NCDs as flagship programme

Experts deliberated on emerging issues in the various fields of Biotechnology and Biomedicine at the fourth BRICS Working Group meeting on the subject area.

1 min read
Bio Spectrum
July 2021
RELATED STORIES

Building a Work of Art

To celebrate the release of the 2022 Indian Chief the legend-ary motorcycle company got together two of the world’s most sought after builders, Paul Cox and Keino Sasaki, to customize a bike for celebrated tattoo artist Nikko Hurtado.

10+ mins read
Inked
Summer lifestyle 2021

Can Bollywood Survive Modi?

Its films have always celebrated a pluralistic India, making the industry—and its Muslim elite—a target of Hindu nationalists.

9 mins read
The Atlantic
July - August 2021

SUJATA MASSEY

Sometimes, an idea needs time to incubate until it’s ready to grow. That was the case with Sujata Massey’s series about Perveen Mistry, a woman attorney practicing in India during the 1920s.

10+ mins read
Mystery Scene
Summer #168 2021

SHOWSTOPPING

THIRTEEN FASCINATING 4X4S from the2020 Fall 4-Wheel Jamboree Nationals

9 mins read
Four Wheeler
July 2021

4X4 PARTY!

Recap of the 39th Annual O’Reilly Auto Parts Fall 4-Wheel Jamboree Nationals

5 mins read
Four Wheeler
July 2021

Klara Landrat & Her Journey with Endometriosis

Klara Landrat is an American-Israeli actress of Polish origin, producer, a writer known for her talent worldwide. She is starring in the Irish TV series – “Gods & Fighting Men” due for release in 2021.

6 mins read
Women Fitness
March 2021

HER MAJESTY PEDDLING HOMEMADE HOOCH!

QUEEN ELIZABETH looks like a dowdy, straitlaced granny, but she’s turned into a heck of a bartender — serving up her own brands of homemade hooch!

1 min read
Globe
May 24, 2021

The Winter of Discontent

Even though america is preparing for a summer reopening, the Coronavirus will still be around to dog us when the temperatures fall.

10+ mins read
Newsweek
May 21 - 28, 2021 (Double Issue)

India thought it had the virus beat. The virus had other ideas

Governments around the world keep repeating the same mistakes. In a country of 1.4 billion, the consequences are on a whole new scale

10+ mins read
Bloomberg Businessweek
May 17, 2021

Reincarnation And Realpolitik

China, India, and the U.S. are vying to influence the selection of the next Dalai Lama

5 mins read
Bloomberg Businessweek
April 19, 2021